DefinitionThis section has been translated automatically.
Glycosylated granulocyte colony stimulating factor produced by recombinant DNA technology.
IndicationThis section has been translated automatically.
Severe neutropenia in patients with non-myeloidal malignant diseases under cytostatic drugs.
You might also be interested in
Dosage and method of useThis section has been translated automatically.
150 μg/m2 KO s.c. or i.v. from the day following the chemotherapy until the expected low point is passed and the neutrophil count is normal Application max. 28 days.
Remember! Do not use 1 day before and on the day of chemotherapy because of the increased sensitivity of rapidly dividing myeloid cells!
Undesirable effectsThis section has been translated automatically.
Alopecia, nausea, vomiting, fever, headache, bone pain, leukocytosis, thrombopenia.
Notice! Check your leukocyte and thrombocyte counts regularly!
ContraindicationThis section has been translated automatically.
Pregnancy, lactation, simultaneous cytotoxic chemotherapy.
PreparationsThis section has been translated automatically.
Granocyte
Prof. Dr. med. Peter Altmeyer